RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Propanc Biopharma Stock

Propanc Biopharma Liabilities 2025

Propanc Biopharma Liabilities

3.85 M USD

Ticker

PPCB

ISIN

US74346N6022

WKN

A2QJDP

In 2025, Propanc Biopharma's total liabilities amounted to 3.85 M USD, a 21.21% difference from the 3.18 M USD total liabilities in the previous year.

Propanc Biopharma Aktienanalyse

What does Propanc Biopharma do?

Propanc Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Propanc Biopharma's Liabilities

Propanc Biopharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Propanc Biopharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Propanc Biopharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Propanc Biopharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Propanc Biopharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Propanc Biopharma stock

What is the level of liabilities of Propanc Biopharma this year?

Propanc Biopharma has a debt balance of 3.85 M USD this year.

What were the liabilities of Propanc Biopharma compared to the previous year?

The liabilities of Propanc Biopharma have increased by 21.21% increased compared to the previous year.

What are the consequences of high debt for investors of Propanc Biopharma?

High liabilities can pose a risk for investors of Propanc Biopharma, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Propanc Biopharma?

Low liabilities mean that Propanc Biopharma has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Propanc Biopharma affect the company?

An increase in liabilities of Propanc Biopharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Propanc Biopharma affect the company?

A decrease in the liabilities of Propanc Biopharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Propanc Biopharma?

Some factors that can influence the liabilities of Propanc Biopharma include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Propanc Biopharma so important for investors?

The liabilities of Propanc Biopharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Propanc Biopharma take to modify the liabilities?

To change its liabilities, Propanc Biopharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Propanc Biopharma pay?

Over the past 12 months, Propanc Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Propanc Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Propanc Biopharma?

The current dividend yield of Propanc Biopharma is .

When does Propanc Biopharma pay dividends?

Propanc Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Propanc Biopharma?

Propanc Biopharma paid dividends every year for the past 0 years.

What is the dividend of Propanc Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Propanc Biopharma located?

Propanc Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Propanc Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Propanc Biopharma from 2/10/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/10/2025.

When did Propanc Biopharma pay the last dividend?

The last dividend was paid out on 2/10/2025.

What was the dividend of Propanc Biopharma in the year 2024?

In the year 2024, Propanc Biopharma distributed 0 USD as dividends.

In which currency does Propanc Biopharma pay out the dividend?

The dividends of Propanc Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Propanc Biopharma

Our stock analysis for Propanc Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Propanc Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.